Oxford University welcomes UK regulatory emergency use authorisation of coronavirus vaccine
The University of Oxford welcomes the news that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK.
Read moreResearch
Research in our Department focuses on a wide variety of aspect of children's health. We study the neuroscience of pain in infants, HIV, immunology, haematology, gastroenterology, neuromuscular diseases and vaccinology.
Teaching
Get involved
What's new
Oxford University welcomes UK regulatory emergency use authorisation of coronavirus vaccine
30 December 2020
The University of Oxford welcomes the news that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK.
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
10 December 2020
University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
University spinout PepGen awarded major financing to target Duchenne muscular dystrophy
9 December 2020
PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.
Oxford University breakthrough on global COVID-19 vaccine
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Latest publications
-
SIMON: Open-Source Knowledge Discovery Platform
Journal article
Tomic A. et al, (2021), Patterns, 2, 100178 - 100178
-
Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study.
Journal article
Annoussamy M. et al, (2020), Ann Clin Transl Neurol
-
RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy.
Journal article
Paolino M. et al, (2020), Nature
-
A guide to vaccinology: from basic principles to new developments.
Journal article
Pollard AJ. and Bijker EM., (2020), Nat Rev Immunol
-
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Journal article
Barrett JR. et al, (2020), Nat Med
-
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Journal article
Ewer KJ. et al, (2020), Nat Med
-
Clinical Genomics for the Diagnosis of Monogenic forms of Inflammatory Bowel Disease
Journal article
Travis S. and UHLIG H., (2020), JPGN
Upcoming events
Online Introduction to Immunisation Training - 19 January 2021
Tuesday, 19 January 2021, 9.30am to 3pm
This training is for general practice nurses and other health professionals who are new to the role of administering and promoting and / or advising about vaccines.
Online Immunisation Update Training - 20 January 2021
Wednesday, 20 January 2021, 9.30am to 12.30pm
Immunisation update training for General Practice Nurses and other registered healthcare practitioners who administer/advise about immunisations within the Thames Valley. A free online Immunisation update training for General Practice Nurses and other registered healthcare practitioners who administer/advise about immunisations in the Thames Valley.
Featured
Oxford-Harrington Rare Diseases Centre
ORDI helps to facilitate relationships between Oxford’s researchers, clinicians, and the wider rare disease community.
Vaccine Knowledge Project
The Vaccine Knowledge Project provides independent. authoritative and accessible scientific information about vaccination.
MDUK Oxford Neuromuscular Centre
We drive the development of novel experimental therapies and increase national clinical trial capacity in neuromuscular diseases.
Paediatric Neuroimaging
The Paediatric Neuroimaging Group aims to improve understanding of human brain development, with a particular focus on improving the treatment of infant pain.
For access to staff pages and student pages, please remember to log into the site with your Oxford Single Sign on at the top right hand side of the page.
If you're not immune to measles you can catch it just by going into a room up to 2 hours after an infected person has left it!
